sr141716 has been researched along with Cancer-Associated Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccone, HA; Ibrahim, MM; Largent-Milnes, TM; Lund, DM; Seltzman, HH; Spigelman, I; Staatz, WD; Vanderah, TW; Zhang, H | 1 |
1 other study(ies) available for sr141716 and Cancer-Associated Pain
| Article | Year |
|---|---|
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
Topics: Analgesics; Animals; Cancer Pain; Cannabinoid Receptor Antagonists; Cell Line, Tumor; Female; Mice; Mice, Inbred BALB C; Musculoskeletal Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Rimonabant; Treatment Outcome | 2018 |